Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Warts × Clear all

Phase

Status

Completed 61 Unknown 15 Recruiting 12 Not yet recruiting 4 Withdrawn 3 Terminated 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 44 Breast Neoplasms 36 Prostatic Neoplasms 26 Colorectal Neoplasms 23 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 16 Neoplasm Metastasis 15 Glioblastoma 15 Brain Neoplasms 14 Pancreatic Neoplasms 13 Melanoma 13 Ovarian Neoplasms 12 Leukemia, Myeloid, Acute 12 Stomach Neoplasms 11 Carcinoma, Hepatocellular 10 Triple Negative Breast Neoplasms 9 Multiple Myeloma 9 Glioma 9 Carcinoma, Renal Cell 9 Myelodysplastic Syndromes 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Rectal Neoplasms 6 Lymphoma 6 Leukemia 6 Head and Neck Neoplasms 6 Esophageal Neoplasms 6 Colonic Neoplasms 6 Uterine Cervical Neoplasms 5 Pain 5 Lymphoma, Large B-Cell, Diffuse 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01796795 2023-09-14

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

G&E Herbal Biotechnology Co., LTD

Phase 2 Suspended

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡